These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30323814)

  • 1. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
    Clark EA; Giltiay NV
    Front Immunol; 2018; 9():2235. PubMed ID: 30323814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
    Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
    J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22 and autoimmune disease.
    Dörner T; Shock A; Smith KG
    Int Rev Immunol; 2012 Oct; 31(5):363-78. PubMed ID: 23083346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
    Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
    Front Immunol; 2018; 9():820. PubMed ID: 29725338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling.
    Giltiay NV; Shu GL; Shock A; Clark EA
    Arthritis Res Ther; 2017 May; 19(1):91. PubMed ID: 28506291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 regulates adaptive and innate immune responses of B cells.
    Kawasaki N; Rademacher C; Paulson JC
    J Innate Immun; 2011; 3(4):411-9. PubMed ID: 21178327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model.
    Wöhner M; Born S; Nitschke L
    Eur J Immunol; 2012 Nov; 42(11):3009-18. PubMed ID: 22965838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.
    Bednar KJ; Shanina E; Ballet R; Connors EP; Duan S; Juan J; Arlian BM; Kulis MD; Butcher EC; Fung-Leung WP; Rao TS; Paulson JC; Macauley MS
    J Immunol; 2017 Nov; 199(9):3116-3128. PubMed ID: 28972089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
    Müller J; Nitschke L
    Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
    Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
    J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
    Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
    Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
    Haas KM; Johnson KL; Phipps JP; Do C
    J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD22 and Siglec-G in B cell function and tolerance.
    Poe JC; Tedder TF
    Trends Immunol; 2012 Aug; 33(8):413-20. PubMed ID: 22677186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
    Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
    Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.